发明名称 Substituted N-methyl-N-(4-(piperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases
摘要 A compound of the formula (I) wherein: R' is from 1 to 3 substituents each independently chosen from the group consisting of hydrogen, halogen, alkyl, and alkoxy; R" is hydrogen or a triazole radical optionally substituted with alkyl or CF3; Ar1 is a radical of formulae (II) wherein: R1 is from 1 to 3 substituents each independently chosen from the group consisting of hydrogen, halogen, hydroxy, -CF3, alkyl, and alkoxy; R2 is from 1 to 2 substituents each independently chosen from the group consisting of hydrogen, halogen, alkyl, and alkoxy; X1 and X2 are as defined in one of parts A), B), or C): A) X1 is hydrogen and X2 is a radical chosen formulae (III) wherein : p is 1 or 2; R3 and R4 are independently selected from 1 to 3 substituents each independently chosen from the group consisting of hydrogen, halogen, -CF3, alkyl, and alkoxy; R5 is hydrogen or hydroxy; Ar2 is a radical chosen from formulae (IV) wherein: R6 is from 1 to 3 substituents each independently chosen from the group consisting of hydrogen, halogen, -CF3, alkyl, alkoxy, and -CO2R9 wherein R9 is chosen from the group consisting of hydrogen and alkyl; R7 is from 1 to 2 substituents each independently chosen from the group consisting of hydrogen, halogen, alkyl, and alkoxy; R8 is chosen from the group consisting of hydrogen,-CH3, and -CH2OH; R10 is chosen from the group consisting of hydrogen, alkyl, and benzyl; Z is chosen from the group consisting of hydrogen, alkyl, -(CH2)w-O-(CH2)t-Y, -(CH2)fA, -(CH2)uCO2R11, -(CH2)uC(O)NR12R13, -(CH2)gC(O)(CH2)hCH3, -(CH2)w-O-Ar3, -CH2CH20CF3, -CH2CF3, -CH2CH2CH2CF3, -(CH2)2CH=CH2, -CH2CH=CH2, -CH2CH=CHCH3, -CK2CH=CKCK2CH3, -CH2CH=C(CH3)2, and -CH2OCH2CH2Si(CH3)3 wherein w is an integer from 2 to 5; t is an integer from 1 to 3; f is 2 or 3; u is an integer from 1 to 4; ; g is an integer from 1 to 3; h is an integer from 0 to 3; w is an integer from 2 to 4; Y is chosen from the group consisting of hydrogen, -CF3, -CH=CH2, -CH=C(CH3)2, and -CO2R14 wherein R14 is chosen from the group consisting of hydrogen and alkyl; A is chosen from the group consisting of -NR15R16, acetylamino, and morpholino wherein R15 is chosen from the group consisting of hydrogen and alkyl and R16 is alkyl; R11 is chosen from the group consisting of hydrogen and alkyl; R12 is chosen from the group consisting of hydrogen, alkyl, and benzyl; R13 is chosen from the group consisting of hydrogen and alkyl; Ar3 is a radical chosen from the group consisting of (V) wherein: v is an integer from 1 to 3; R17 is chosen from the group consisting of hydrogen and -C02R18 wherein R18 is chosen from the group consisting of hydrogen and alkyl; B) X1 is hydroxy and X2 is a radical chosen from the group consisting of formulae (VI) wherein p, R3, Z, and Ar2 are as previously defined; C) X2 is a radical of the formula (VII) wherein R3 and R4 are as previously defined; and X1 and Z1 taken together form a second bond between the carbon atoms bearing X1 and Z1; and stereoisomers and pharmaceutically acceptable salt thereof. The compounds are useful for treating allergic rhinitis, asthma, emesis and inflammatory bowel disease.
申请公布号 NZ330910(A) 申请公布日期 2001.05.25
申请号 NZ19970330910 申请日期 1997.01.27
申请人 AVENTIS PHARMACEUTICALS INC 发明人 MAYNARD, GEORGE DANIEL;KANE, JOHN MICHAEL;KUDLACZ, ELIZABETH MARY;BRATTON, LARRY DON
分类号 A61K31/445;A61K31/454;A61K31/4545;A61K31/5377;A61P1/04;A61P1/08;A61P11/06;A61P27/16;A61P37/08;A61P43/00;C07D211/22;C07D211/70;C07D401/04;C07D401/06;C07D401/14;C07D405/14;C07D409/14;C07D417/06;(IPC1-7):C07D417/06 主分类号 A61K31/445
代理机构 代理人
主权项
地址